"HER-Vaxx is progressing in the Phase 2 clinical trial by dosing further patients with its HER-Vaxx (IMU-131) cancer immunotherapy for the treatment of HER-2 positive gastric cancer patients."
They wouldn't be doing that if it wasn't showing positive signs.
Ann: Appendix 4C - quarterly, page-3
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.2¢ |
Change
0.001(1.96%) |
Mkt cap ! $373.3M | |||
| Open | High | Low | Value | Volume |
| 5.1¢ | 5.3¢ | 5.0¢ | $516.5K | 10.06M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 549831 | 5.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.2¢ | 786321 | 10 |
View Market Depth
| Last trade - 15.57pm 04/07/2024 (20 minute delay) ? |
| IMU (ASX) Chart |